Harrow Health, Inc. announces that the company will locate its headquarters operations in Nashville. Harrow Health, Inc., owns a portfolio of health care businesses, including the nation’s leading ophthalmology pharmaceutical compounding business, ImprimisRx. The company holds large equity positions in Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals and Radley Pharmaceuticals, all companies founded as subsidiaries of Harrow Health.
The Company also owns royalty rights in certain 505(b)(2) drug candidates being developed by Surface, Melt, Mayfield and Radley. Harrow aims to create, invest in and grow paradigm shifting health care businesses that put patients first.
